Stanford student gaining cult status for rethinking NBA philosophy
Muthu Alagappan arrived at Stanford University with his heart set on attending medical school, and he still hopes to become a doctor someday.
Muthu Alagappan arrived at Stanford University with his heart set on attending medical school, and he still hopes to become a doctor someday.
Mathematics
Jun 20, 2013
0
0
Drug-resistant bacteria responsible for deadly hospital-acquired infections shut out antibiotics by closing tiny doors in their cell walls.
Cell & Microbiology
Sep 2, 2019
0
427
There's a useful concept from psychology that helps explain why good people do things that harm the environment: the false consensus effect. That's where we overestimate how acceptable and prevalent our own behavior is in ...
Environment
Feb 15, 2021
0
196
Chemistry researchers at the University of Bath have developed a new method using blue light to create pharmaceuticals in a more sustainable way, significantly reducing the amount of energy needed and the chemical waste created ...
Materials Science
Nov 17, 2021
0
206
A team of researchers at Kwansei Gakuin University in Japan has found a way to synthesize small cyclodextrins (types of cyclic oligosaccharides) for the first time. In their paper published in the journal Science, the group ...
Demand for new kinds of antibiotics is surging, as drug-resistant and emerging infections are becoming an increasingly serious global health threat. Researchers are racing to reexamine certain microbes that serve as one of ...
Cell & Microbiology
Apr 11, 2022
0
139
An innovative genetic study of blood protein levels, led by researchers in the MRC Integrative Epidemiology Unit (MRC-IEU) at the University of Bristol, has demonstrated how genetic data can be used to support drug target ...
Biotechnology
Sep 7, 2020
0
56
Selecting the most effective molecules for drug delivery is often a trial-and-error process, but Cornell engineers are providing some precision thanks to a technique that reveals the performance of those molecules inside ...
Biochemistry
Nov 2, 2019
0
123
A new "organocatalyst" developed at Oregon State University is now available for commercial use. Produced by an Albany, Ore., pharmaceutical company, it should make new drug development around the world less costly, more ...
Materials Science
May 11, 2011
0
0
A new stem cell-derived system for screening experimental drugs for cardiotoxicity could identify dangerous side effects early in the development process, thereby potentially saving time, lives and money, according to Evan ...
Cell & Microbiology
Dec 17, 2012
0
0